APACHE II Score Calculator
Calculate APACHE II score for ICU mortality prediction. Uses acute physiology, age, and chronic health evaluation.
About APACHE II
What is APACHE II?
The Acute Physiology and Chronic Health Evaluation II (APACHE II) was developed by Knaus et al. in 1985. It remains one of the most widely used ICU severity scoring systems, despite being over 35 years old.
Components
APACHE II score (0-71 points) comprises three components:
- Acute Physiology Score (0-60 points): 12 physiological variables, using worst values in first 24 hours
- Age Points (0-6 points): Increasing with age
- Chronic Health Points (0-5 points): For severe chronic organ insufficiency or immunocompromise
Acute Physiology Variables
- Temperature
- Mean arterial pressure
- Heart rate
- Respiratory rate
- Oxygenation (PaO₂ or A-a gradient)
- Arterial pH
- Serum sodium
- Serum potassium
- Serum creatinine
- Haematocrit
- White blood cell count
- Glasgow Coma Scale
APACHE II Score and Mortality
| APACHE II Score | Approximate Mortality | Risk Category |
|---|---|---|
| 0-4 | ~4% | Low risk |
| 5-9 | ~8% | Low risk |
| 10-14 | ~15% | Moderate risk |
| 15-19 | ~25% | Moderate risk |
| 20-24 | ~40% | High risk |
| 25-29 | ~55% | High risk |
| 30-34 | ~75% | Very high risk |
| ≥35 | ~85% | Extremely high risk |
Mortality estimates are approximate and based on original APACHE II data from the 1980s. Modern ICU mortality rates are generally lower due to advances in critical care.
Limitations
- Dated validation: Developed in 1985 - modern ICU care has improved outcomes significantly
- Population-level tool: Not validated for individual prognosis or treatment decisions
- Diagnosis-dependent: Mortality varies significantly by primary diagnosis (e.g., sepsis vs. DKA)
- Lead-time bias: Patients transferred from other ICUs may have artificially high scores
- Not for serial use: Designed for admission scoring only, not for tracking daily changes
- Missing variables: Does not account for many important prognostic factors
Alternatives
- APACHE III/IV: More complex, proprietary systems with diagnosis-specific weighting
- SAPS II/3: Simplified Acute Physiology Score - similar purpose
- SOFA: Focuses on organ dysfunction, useful for serial monitoring
- MPM: Mortality Probability Models - for admission and 24/48-hour assessment
Frequently Asked Questions
References
- Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-829. PubMed
- Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100(6):1619-1636. PubMed
- Intensive Care National Audit & Research Centre (ICNARC). ICNARC
- Vincent JL, Moreno R. Clinical review: Scoring systems in the critically ill. Crit Care. 2010;14(2):207. PMC
Disclaimer
This calculator is provided for educational and informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
- Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition.
- Never disregard professional medical advice or delay seeking it because of information from this tool.
- Clinical decision-making should always incorporate the full clinical context, patient preferences, and local protocols.
- The creators of this tool accept no liability for decisions made based on its output.
If you are a patient: please discuss any results with your healthcare provider. This tool is designed for use by medical professionals and may not be appropriate for self-assessment.
Quick Reference
APACHE II Components
- Acute Physiology: 0-60 pts
- Age: 0-6 pts
- Chronic Health: 0-5 pts
- Total: 0-71 pts
Key Thresholds
- <10: Low mortality risk
- 10-19: Moderate risk
- 20-29: High risk
- ≥30: Very high risk
Related Tools
Clinical Pearl
APACHE II was validated in the 1980s. Modern ICU care has significantly improved outcomes, so actual mortality rates are typically lower than APACHE II predictions. Use for benchmarking and quality improvement, not individual prognosis.